Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
European Urology Focus
|
September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation
Stephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
Clinical and Translational Radiation Oncology
|
February 9, 2026
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review
Lara Caglayan, Oliver Blanck, Judit Boda-Heggemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [<sup>68</sup>Ga]PSMA-PET-guided metastasis-directed therapy
Marco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)
Sina Heider, Luisa Allwohn, Alexander Rühle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)
Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
Neuro-Oncology
|
October 11, 2017
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
Tobias Kessler, Felix Sahm, Ahmed Sadik, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 22, 2019
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy
Rainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference
Constantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 29, 2022
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment
Denise Bernhardt, Laila König, Anca-L Grosu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments
Rainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
European Urology Focus
|
September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation
Stephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
Clinical and Translational Radiation Oncology
|
February 9, 2026
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review
Lara Caglayan, Oliver Blanck, Judit Boda-Heggemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [<sup>68</sup>Ga]PSMA-PET-guided metastasis-directed therapy
Marco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)
Sina Heider, Luisa Allwohn, Alexander Rühle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)
Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
Neuro-Oncology
|
October 11, 2017
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
Tobias Kessler, Felix Sahm, Ahmed Sadik, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 22, 2019
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy
Rainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference
Constantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 29, 2022
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment
Denise Bernhardt, Laila König, Anca-L Grosu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments
Rainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.
Page
of 18